COO Stock Declines Despite Strong Core Growth Amid Fertility Woes
Key Takeaways COO grew EPS 14% and expanded operating margin to 24.9% despite macro challenges. Strong gains for COO's MyDay lenses and surgical devices offset weaker fertility and Asia demand. Inventory destocking and tariff risks may pressure COO's revenues and EPS into in fiscal 2026. The Cooper Companies, Inc.’s (COO) strategic investments in innovation and its diversified product base support long-term growth. However, near-term macro and inventory challenges, particularly in fertility and global con ...